SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia.

Price, J; Baker, G; Heath, I; Walker-Bone, K; Cubbon, M; Curtis, S; Enright, MC; Lindsay, J; Paul, J; Llewelyn, M (2010) Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia. International Journal of Microbiology, 2010 (654858). ISSN 1687-9198 https://doi.org/10.1155/2010/654858
SGUL Authors: Lindsay, Jodi Anne

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (505kB) | Preview

Abstract

Staphylococcus aureus bacteraemia (SAB) is commonly complicated by metastatic infection or relapse after treatment. Objectives. The study aim was to determine the role of bacterial, host, and management factors in development of complicated SAB. Methods. A prospectively-conducted observational study gathered data on predisposition, management and outcome of 100 consecutive SAB cases. Antibiotic susceptibilities and genetic lineage of bacterial isolates were determined. Further clinical and microbiological data were gathered on two retrospective series from 1999-2000 (n = 57) and 2004 (n = 116). Results. In the prospective cases, 27% met our definition of complicated disease. Expressed as RR and 95% CI, complicated disease was associated with diabetes (1.58, 1.00-2.48), injecting-drug use (5.48, 0.88-33.49), community-onset of symptoms (1.4, 1.02-1.92), and symptom duration >/=48 hours prior to starting effective antibiotic therapy (2.10, 1.22-3.61). Uncomplicated disease was associated with the presence of a central line (0.69, 0.55-0.88) and prompt removal of a primary focus (0.71, 0.57-0.90). Neither methicillin resistance nor genetic lineage was associated with complicated disease, but methicillin resistance was associated with higher mortality. Conclusions. This study demonstrates that clinical rather than microbial factors are the major determinants of SAB outcome and underscores the importance of early treatment.

Item Type: Article
Additional Information: PMCID: PMC2840372 © 2010 James Price et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: International Journal of Microbiology
ISSN: 1687-9198
Dates:
DateEvent
16 March 2010Published
PubMed ID: 20300477
Web of Science ID: 20300477
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/1809
Publisher's version: https://doi.org/10.1155/2010/654858

Actions (login required)

Edit Item Edit Item